Rain Oncology Inc. Operating Expenses
Rain Oncology Inc. reported Operating Expenses of $8.08 million for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2023-11-09
- Rain Oncology Inc. operating expenses for the quarter ending 2023-09-30 was $8.08M, a 56.12% decline year-over-year.
- Rain Oncology Inc. operating expenses for the quarter ending 2023-06-30 was $23.23M, a 31.12% increase year-over-year.
- Rain Oncology Inc. operating expenses for the quarter ending 2023-03-31 was $21.74M, a 24.60% increase year-over-year.
- Rain Oncology Inc. operating expenses for the quarter ending 2022-12-31 was $23.56M, a 30.31% increase year-over-year.
- Rain Oncology Inc. operating expenses for fiscal 2022 was $77.14M, a 49.74% increase from fiscal 2021.
- Rain Oncology Inc. operating expenses for fiscal 2021 was $51.51M, a 171.72% increase from fiscal 2020.
- Rain Oncology Inc. operating expenses for fiscal 2020 was $18.96M.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2023-09-30 | $8.08M 10-Q · filed 2023-11-09 | $31.31M derived: sum of 2 quarters · filed 2023-11-09 | $53.05M 10-Q · filed 2023-11-09 | $76.61M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $23.23M 10-Q · filed 2023-08-10 | $44.97M 10-Q · filed 2023-08-10 | $68.53M derived: sum of 3 quarters · filed 2023-08-10 | $86.94M derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $21.74M 10-Q · filed 2023-05-11 | $45.30M derived: sum of 2 quarters · filed 2023-05-11 | $63.71M derived: sum of 3 quarters · filed 2023-11-09 | $81.43M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $23.56M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $41.97M derived: sum of 2 quarters · filed 2023-11-09 | $59.69M derived: sum of 3 quarters · filed 2023-11-09 | $77.14M 10-K · filed 2023-03-09 |
| 2022-09-30 | $18.41M 10-Q · filed 2023-11-09 | $36.13M derived: sum of 2 quarters · filed 2023-11-09 | $53.58M 10-Q · filed 2023-11-09 | $71.66M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $17.72M 10-Q · filed 2023-08-10 | $35.17M 10-Q · filed 2023-08-10 | $53.24M derived: sum of 3 quarters · filed 2023-08-10 | $71.68M derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $17.45M 10-Q · filed 2023-05-11 | $35.53M derived: sum of 2 quarters · filed 2023-05-11 | $53.97M derived: sum of 3 quarters · filed 2023-05-11 | $62.15M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $18.08M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $36.52M derived: sum of 2 quarters · filed 2023-03-09 | $44.70M derived: sum of 3 quarters · filed 2023-03-09 | $51.51M 10-K · filed 2023-03-09 |
| 2021-09-30 | $18.44M 10-Q · filed 2022-11-10 | $26.63M derived: sum of 2 quarters · filed 2022-11-10 | $33.44M 10-Q · filed 2022-11-10 | $38.89M derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $8.19M 10-Q · filed 2022-08-04 | $15.00M 10-Q · filed 2022-08-04 | $20.45M derived: sum of 3 quarters · filed 2022-08-04 | $28.93M derived: sum of 4 quarters · filed 2022-08-04 |
| 2021-03-31 | $6.81M 10-Q · filed 2022-05-04 | $12.26M derived: sum of 2 quarters · filed 2022-05-04 | $20.74M derived: sum of 3 quarters · filed 2022-05-04 | $23.34M derived: sum of 4 quarters · filed 2022-05-04 |
| 2020-12-31 | $5.45M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $13.94M derived: sum of 2 quarters · filed 2022-03-03 | $16.53M derived: sum of 3 quarters · filed 2022-03-03 | $18.96M 10-K · filed 2022-03-03 |
| 2020-09-30 | $8.48M 10-Q · filed 2021-11-10 | $11.08M derived: sum of 2 quarters · filed 2021-11-10 | $13.51M 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $2.59M 10-Q · filed 2021-08-10 | $5.02M 10-Q · filed 2021-08-10 | ||
| 2020-03-31 | $2.43M 10-Q · filed 2021-05-25 |